141 related articles for article (PubMed ID: 11238550)
21. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
22. [Rearrangement of the RET gene in papillary thyroid carcinoma].
Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
[TBL] [Abstract][Full Text] [Related]
23. RET proto-oncogene mutations in thyroid carcinomas: clinical relevance.
Pacini F; Elisei R; Romei C; Pinchera A
J Endocrinol Invest; 2000 May; 23(5):328-38. PubMed ID: 10882153
[TBL] [Abstract][Full Text] [Related]
24. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.
Klugbauer S; Rabes HM
Oncogene; 1999 Jul; 18(30):4388-93. PubMed ID: 10439047
[TBL] [Abstract][Full Text] [Related]
25. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
Rabes HM; Demidchik EP; Sidorow JD; Lengfelder E; Beimfohr C; Hoelzel D; Klugbauer S
Clin Cancer Res; 2000 Mar; 6(3):1093-103. PubMed ID: 10741739
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
Bounacer A; Wicker R; Caillou B; Cailleux AF; Sarasin A; Schlumberger M; Suárez HG
Oncogene; 1997 Sep; 15(11):1263-73. PubMed ID: 9315093
[TBL] [Abstract][Full Text] [Related]
27. Challenging dogma in thyroid cancer molecular genetics--role of RET/PTC and BRAF in tumor initiation.
Fagin JA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4264-6. PubMed ID: 15356019
[No Abstract] [Full Text] [Related]
28. The ret/PTC oncogene in papillary thyroid carcinoma.
Jhiang SM; Mazzaferri EL
J Lab Clin Med; 1994 Mar; 123(3):331-7. PubMed ID: 8133143
[No Abstract] [Full Text] [Related]
29. Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma.
Musholt TJ; Musholt PB; Khaladj N; Schulz D; Scheumann GF; Klempnauer J
Surgery; 2000 Dec; 128(6):984-93. PubMed ID: 11114633
[TBL] [Abstract][Full Text] [Related]
30. RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
Viglietto G; Chiappetta G; Martinez-Tello FJ; Fukunaga FH; Tallini G; Rigopoulou D; Visconti R; Mastro A; Santoro M; Fusco A
Oncogene; 1995 Sep; 11(6):1207-10. PubMed ID: 7566982
[TBL] [Abstract][Full Text] [Related]
31. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.
Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Cancer Res; 1998 Jan; 58(2):198-203. PubMed ID: 9443391
[TBL] [Abstract][Full Text] [Related]
32. ret rearrangements in Japanese pediatric and adult papillary thyroid cancers.
Motomura T; Nikiforov YE; Namba H; Ashizawa K; Nagataki S; Yamashita S; Fagin JA
Thyroid; 1998 Jun; 8(6):485-9. PubMed ID: 9669285
[TBL] [Abstract][Full Text] [Related]
33. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer.
Fugazzola L; Pierotti MA; Vigano E; Pacini F; Vorontsova TV; Bongarzone I
Oncogene; 1996 Sep; 13(5):1093-7. PubMed ID: 8806699
[TBL] [Abstract][Full Text] [Related]
34. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
35. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas.
Cetta F; Chiappetta G; Melillo RM; Petracci M; Montalto G; Santoro M; Fusco A
J Clin Endocrinol Metab; 1998 Mar; 83(3):1003-6. PubMed ID: 9506763
[TBL] [Abstract][Full Text] [Related]
36. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation.
Mizuno T; Iwamoto KS; Kyoizumi S; Nagamura H; Shinohara T; Koyama K; Seyama T; Hamatani K
Oncogene; 2000 Jan; 19(3):438-43. PubMed ID: 10656692
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas.
Unger K; Zitzelsberger H; Salvatore G; Santoro M; Bogdanova T; Braselmann H; Kastner P; Zurnadzhy L; Tronko N; Hutzler P; Thomas G
J Clin Endocrinol Metab; 2004 Sep; 89(9):4272-9. PubMed ID: 15356021
[TBL] [Abstract][Full Text] [Related]
38. RET oncogene activation in papillary thyroid carcinoma.
Tallini G; Asa SL
Adv Anat Pathol; 2001 Nov; 8(6):345-54. PubMed ID: 11707626
[TBL] [Abstract][Full Text] [Related]
39. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
[TBL] [Abstract][Full Text] [Related]
40. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]